Certain Ordinary Shares of BioInvent International AB (publ) are subject to a Lock-Up Agreement Ending on 11-JAN-2023. These Ordinary Shares will be under lockup for 183 days starting from 12-JUL-2022 to 11-JAN-2023.

Details:
In connection with the Directed Share Issue, the Company has undertaken, subject to customary exceptions and the completion of the Directed Share Issue, to not issue additional shares for a period of 180 days as from announcement of the Directed Share Issue. In addition, shareholding members of the Board of Directors and management of BioInvent have undertaken to not sell shares in the Company for a period of 90 days as from settlement of the Directed Share Issue, subject to customary exceptions.